What the new Anti-Markup Rule means for your practice

Molife, Nicole Liffrig
January 2009
Ocular Surgery News;1/10/2009, Vol. 27 Issue 1, p40
Academic Journal
The author explains the significance of an anti-markup rule for diagnostic tests issued by the U.S. Centers for Medicare and Medicaid Services for ophthalmology practice in the country. She provides an overview of the rule. She claims that the anti-markup rule affects how physicians and physician practices provide diagnostic imaging services. The author calls for physicians to carefully review their diagnostic imaging arrangements to comply with the anti-markup rule.


Related Articles

  • HIPAA's Temporary Reprieve. Morrison, Malcolm H. // Nursing Homes: Long Term Care Management;Nov2003, Vol. 52 Issue 11, p66 

    Reports on the decision of the U.S. Centers for Medicare and Medicaid Services (CMS) to accept health care claims that are noncompliant with the Health Insurance Portability and Accountability Act's electronic transactions and code set provisions. Ramifications of the decision; Benefits of the...

  • Being prepared is your best defense when RACs request records.  // Hospital Case Management;Dec2010, Vol. 18 Issue 12, p177 

    The article reports that U.S. hospitals should quickly respond when Recovery Audit Contractor (RAC) programs ask for hospital bills and documentation. According to Administrative Consultant Services LLC president Deborah Hale, hospitals could reduce their risks of losing revenue if they...

  • CMS affirms it will let MACs decide on infrequent services. McCARTY, MARK // Medical Device Daily;12/3/2013, Vol. 17 Issue 232, p1 

    The article reports on the decision by the U.S. Centers for Medicare and Medicaid Services (CMS) to use an administrative review process to delete items from the coverage manual in 2013. Topics discussed include CMS' update of the process used in making changes to the national coverage...

  • CMS opens NCA for PET as diagnostic.  // Medical Device Daily;1/8/2009, Vol. 13 Issue 4, p2 

    The article focuses on the decision of the U.S. Centers for Medicare & Medicaid Services (CMS) to conduct a national coverage analysis for the use of positron-emission tomography (PET) as a first-line diagnosis for suspected cancer. The accumulation of data urged CMS to consider PET for routine...

  • MITA; CMS blew it on PET/Alzheimer's.  // Medical Device Daily;7/11/2013, Vol. 17 Issue 132, p9 

    The article reports on the announcement made by the Centers for Medicare & Medicaid Services that it will offer only conditional coverage of positron emission tomography (PET) imaging for detection of the beta amyloid characteristic of alzheimer's disease.

  • 'Present on admission' could have big effect.  // Hospital Case Management;Oct2007, Vol. 15 Issue 10, p147 

    The article reports that hospitals will have to report the present on admission indicator for every diagnosis reported for a patient in the U.S., beginning on October 1, 2008. It states that the U.S. Centers for Medicare and Medicaid Services will not assign a higher-paying diagnostic related...

  • Capsule Commentary on Zafar et al., Predictor of CT Colonography Utilization Among Asymptomatic Medicare Beneficiaries. Cooper, Gregory // JGIM: Journal of General Internal Medicine;Sep2013, Vol. 28 Issue 9, p1224 

    The author discusses the study of H. M. Zafar and colleagues regarding the use of computed tomography colonography (CTC) among Medicare beneficiaries. The author mentions that CTC use in primary screening is low even if insurance reimbursement under the U.S. Centers for Medicare and Medicaid...

  • Supplement Your 99218-99220 Descriptors With Added Time Guidelines.  // Pulmonology Coding Alert;Dec2011, Vol. 12 Issue 12, p83 

    The article focuses on the new codes 99218-99220 and modifier for preventive service included in the Current Procedural Terminology (CPT)® manual. It says that the new codes will take effect on January 1, 2012 and feature typical times associated with initial observation care. According to...

  • CMS announces apnea coverage.  // Medical Device Daily;3/5/2009, Vol. 13 Issue 42, p11 

    The article reports on an announcement made by the U.S. Centers for Medicare & Medicaid Services (CMS) on March 3, 2009 regarding its reimbursement policy for testing to diagnose obstructive sleep apnea (OSA) and its decision to cover type II and III testing devices inside or outside of a sleep...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics